Attached files

file filename
8-K - 8-K - Genpact LTDg-8k_20210209.htm

Exhibit 99.1

 

Genpact Reports Full Year and Fourth Quarter 2020 Results

2020 Total Revenue of $3.7 billion, Up 5% (6% on a constant currency basis)1

2020 Global Client Revenue of $3.3 billion, Up 7%2

2020 Diluted EPS of $1.57, Up 1%; Adjusted Diluted EPS3 of $2.12, Up 3%

Quarterly Cash Dividend Increased By 10%

Board Approves $500 Million Increase to Share Repurchase Program

NEW YORK, February 9, 2021 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the fourth quarter and full year ended December 31, 2020.

 

“Our performance during 2020 reflects our agility and culture of embracing change that allowed us to rapidly meet client needs and successfully pivot to new ways of working,” said “Tiger” Tyagarajan, Genpact’s president and CEO. “Led by the dedication of our global workforce, our ability to grow our top and bottom line is a testament to the resiliency of our business. The acceleration of digital transformation into new buying centers across all industries is expanding our total addressable market and providing us with many more opportunities to drive sustainable and profitable long-term growth.”

 

Key Financial Highlights – Full Year 2020

Total revenue was $3.7 billion, up 5% year-over-year (6% on a constant currency basis).1

Revenue from Global Clients was $3.3 billion, up 7% year-over-year, both on an as reported and constant currency basis1, representing 88% of total revenue.

Revenue from GE was $459 million, down 4% year-over-year, representing 12% of total revenue.

Net income attributable to Genpact Limited shareholders was $308 million, up 1% year-over-year, with a corresponding margin of 8.3%.

Income from operations was $439 million, up 2% year-over-year, with a corresponding margin of 11.8%.   Adjusted income from operations was $589 million, up 5% year-over-year, with a corresponding margin of 15.9%.4

Diluted earnings per share was $1.57, up 1% year-over-year, and adjusted diluted earnings per share3 was $2.12, up 3% year-over-year.

Income from operations and diluted earnings per share include $26.5 million of restructuring charges related to employee severance costs and lease impairment charges recorded in the second and third quarters of 2020.  These restructuring charges are excluded from adjusted income from operations4 and adjusted diluted earnings per share.3

New bookings were approximately $3.1 billion, down 20% year-over-year.  Global Client new bookings were down 8% year-over-year.5

 

1 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.

2 Both on an as reported and constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating
current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted
for hedging gains/losses in such period.

3 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.

4 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from
operations and GAAP net income to adjusted income from operations and GAAP income from operations margin and GAAP net income margin to

adjusted income from operations margin are attached to this release.

5 New bookings, an operating measure, represents the total contract value of new contracts and certain renewals, extensions and changes to existing contracts.  Regular renewals of contracts with no change in scope are not counted as new bookings.

 


 

Cash generated from operations was $584 million, up 36% from $428 million in 2019.

Genpact repurchased approximately 3.4 million of its common shares for total consideration of approximately $137 million at an average price per share of $40.16.

Key Financial Highlights – Fourth Quarter 2020

Total revenue was $951 million, up 1% year-over-year, both on an as reported and constant currency basis.1

Revenue from Global Clients was $841 million, up 4% year-over-year (3% on a constant currency basis)1, representing 89% of total revenue.

Revenue from GE was $109 million, down 16% year-over-year, representing 11% of total revenue.

Net income was $75 million, down 9% year-over-year, with a corresponding margin of 7.9%.

Income from operations was $113 million, down 5% year-over-year, with a corresponding margin of 11.9%.   Adjusted income from operations was $148 million, down 7% year-over-year, with a corresponding margin of 15.5%.4

Diluted earnings per share was $0.38, down 10% year-over-year, and adjusted diluted earnings per share3 was $0.51, down 11% year-over-year.

Cash generated from operations was $159 million, up 83% from $87 million in the fourth quarter of 2019.

Genpact repurchased approximately 1.6 million of its common shares during the quarter for total consideration of approximately $63 million at an average price per share of $38.94.

Capital Allocation

Genpact’s Board of Directors approved a quarterly cash dividend of $0.1075, a 10% increase, payable on March 19, 2021 to shareholders of record as of the close of business on March 10, 2021, and an increase of $500 million to the Company’s existing share repurchase authorization.

Full Year 2021 Outlook

 

Genpact expects:

Total revenue of $3.93 to $3.99 billion, up 6% to 7.5%, or 5.0% to 6.5% on a constant currency basis.1  

Global Client revenue growth in the range of 8.0% to 10%, or 7.0% to 9.0% on a constant currency basis.1

Adjusted income from operations margin6 of approximately 16.0%.

Adjusted diluted EPS7 of $2.26 to $2.29.

Conference Call to Discuss Financial Results

Genpact’s management will host an hour-long conference call beginning at 4:30 p.m. ET on February 9, 2021 to discuss the company’s performance for the fourth quarter and full year ended December 31, 2020. To participate, callers can dial +1 (877) 654-0173 from within the U.S. or +1 (281) 973-6289 from any other country. Callers will be prompted to enter the conference ID, 5589896.

 

A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the Genpact website after the end of the call. A transcript of the call will also be made available on the website.

 

 

 

 

 

6 Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin is attached to this release.

7Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.

 


 


 

About Genpact

Genpact (NYSE: G) is a global professional services firm that makes business transformation real. We drive digital-led innovation and digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes primarily for Global Fortune 500 companies. We think with design, dream in digital, and solve problems with data and analytics.  Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 90,000+ of us. From New York to New Delhi and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent companies’ ways of working. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we’ll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here.

Safe Harbor

This press release contains certain statements concerning our future growth prospects, including our outlook for 2021, financial results, intention to pay dividends or repurchase our common shares and other forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements. These risks, uncertainties, and other factors include but are not limited to the impact of the COVID-19 pandemic on our business, the health and safety of our employees, clients, partners and suppliers, as well as the physical and economic impacts of the various recommendations, orders and protocols issued by local and national governmental agencies in response to the pandemic, a slowdown in the economies and sectors in which our clients operate, a slowdown in the business process outsourcing or information technology services sectors, our ability to develop and successfully execute our business strategies, the risks and uncertainties arising from our past and future acquisitions, our ability to convert bookings to revenues, our ability to manage growth, factors which may impact our cost advantage, wage increases, changes in tax rates and tax legislation and other laws and regulations, our ability to attract and retain skilled professionals, risks and uncertainties regarding fluctuations in our earnings, foreign currency fluctuations, general economic conditions affecting our industry, political, economic or business conditions in countries in which we operate, the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, as well as other risks detailed in our reports filed with the U.S. Securities and Exchange Commission, including Genpact's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available at www.sec.gov. Genpact may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. Although Genpact believes that these forward-looking statements are based on reasonable assumptions, you are cautioned not to put undue reliance on these forward-looking statements, which reflect management's current analysis of future events and should not be relied upon as representing management's expectations or beliefs as of any date subsequent to the time they are made. Genpact undertakes no obligation to update any forward-looking statements that may be made from time to time by or on behalf of Genpact.

Contacts

 

Investors

  

Roger Sachs, CFA

 

  

+1 (203) 808-6725

 

  

roger.sachs@genpact.com

 

 

Media

  

Michael Schneider

+1 (217) 260-5041

michael.schneider@genpact.com

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)

 

 

 

As of December 31,

2019

 

 

As of December 31,

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

467,096

 

 

$

680,440

 

Accounts receivable, net of reserve for doubtful receivables of $29,969 and allowance for credit losses of $27,707 as of December 31, 2019 and 2020, respectively

 

 

914,255

 

 

 

881,020

 

Prepaid expenses and other current assets

 

 

170,325

 

 

 

187,408

 

Total current assets

 

$

1,551,676

 

 

$

1,748,868

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

254,035

 

 

 

231,122

 

Operating lease right-of-use assets

 

 

330,854

 

 

 

304,714

 

Deferred tax assets

 

 

89,715

 

 

 

106,674

 

Intangible assets, net

 

 

230,861

 

 

 

236,732

 

Goodwill

 

 

1,574,466

 

 

 

1,695,688

 

Contract cost assets

 

 

205,498

 

 

 

225,897

 

Other assets, net of reserve for doubtful assets of $0 and allowance for credit losses of $3,134 as of December 31, 2019 and 2020, respectively

 

 

217,079

 

 

 

323,818

 

Total assets

 

$

4,454,184

 

 

$

4,873,513

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Short-term borrowings

 

$

70,000

 

 

$

250,000

 

Current portion of long-term debt

 

 

33,509

 

 

 

33,537

 

Accounts payable

 

 

21,981

 

 

 

13,910

 

Income taxes payable

 

 

43,186

 

 

 

41,941

 

Accrued expenses and other current liabilities

 

 

683,871

 

 

 

806,769

 

Operating leases liability

 

 

57,664

 

 

 

56,479

 

Total current liabilities

 

$

910,211

 

 

$

1,202,636

 

 

 

 

 

 

 

 

 

 

Long-term debt, less current portion

 

 

1,339,796

 

 

 

1,307,371

 

Operating leases liability

 

 

302,100

 

 

 

289,363

 

Deferred tax liabilities

 

 

3,990

 

 

 

1,516

 

Other liabilities

 

 

208,916

 

 

 

238,398

 

Total liabilities

 

$

2,765,013

 

 

$

3,039,284

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

 

 

Preferred shares, $0.01 par value, 250,000,000 authorized, none issued

 

 

 

 

 

 

Common shares, $0.01 par value, 500,000,000 authorized 190,118,181 and 189,045,661 issued and outstanding as of December 31, 2019 and 2020, respectively

 

 

1,896

 

 

 

1,885

 

Additional paid-in capital

 

 

1,570,575

 

 

 

1,636,026

 

Retained earnings

 

 

648,656

 

 

 

741,658

 

Accumulated other comprehensive income (loss)

 

 

(531,956

)

 

 

(545,340

)

Total equity

 

$

1,689,171

 

 

$

1,834,229

 

 

 

 

 

 

 

 

 

 

Total liabilities and equity

 

$

4,454,184

 

 

$

4,873,513

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

 

 

 

Three months ended December 31,

 

 

 

2018

 

 

2019

 

 

2020

 

Net revenues

 

$

835,339

 

 

$

940,739

 

 

$

950,568

 

Cost of revenue

 

 

533,134

 

 

 

630,648

 

 

 

613,645

 

Gross profit

 

$

302,205

 

 

$

310,091

 

 

$

336,923

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

178,580

 

 

 

212,650

 

 

 

207,860

 

Amortization of acquired intangible assets

 

 

9,716

 

 

 

9,047

 

 

 

11,670

 

Other operating (income) expense, net

 

 

3,068

 

 

 

(31,124

)

 

 

4,340

 

Income from operations

 

$

110,841

 

 

$

119,518

 

 

$

113,053

 

Foreign exchange gains (losses), net

 

 

186

 

 

 

4,083

 

 

 

(4,129

)

Interest income (expense), net

 

 

(9,473

)

 

 

(9,971

)

 

 

(10,888

)

Other income (expense), net

 

 

5,078

 

 

 

719

 

 

 

2,292

 

Income before equity-method investment activity, net and income tax expense

 

$

106,632

 

 

$

114,349

 

 

$

100,328

 

Equity-method investment activity, net

 

 

10

 

 

 

 

 

 

 

Income before income tax expense

 

$

106,642

 

 

$

114,349

 

 

$1,00,328

 

Income tax expense

 

 

27,495

 

 

 

32,151

 

 

 

25,346

 

Net income

 

$

79,147

 

 

$

82,198

 

 

$

74,982

 

Net loss (income) attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

79,147

 

 

$

82,198

 

 

$

74,982

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to Genpact Limited common shareholders

 

$

79,147

 

 

$

82,198

 

 

$

74,982

 

Earnings per common share attributable to Genpact Limited common

Shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.42

 

 

$

0.43

 

 

$

0.40

 

Diluted

 

$

0.41

 

 

$

0.42

 

 

$

0.38

 

Weighted average number of common shares used in computing earnings per common share attributable to Genpact Limited common shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

189,724,744

 

 

 

190,083,647

 

 

 

189,470,107

 

Diluted

 

 

193,149,836

 

 

 

196,592,325

 

 

 

194,823,683

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

 

 

 

Year ended December 31,

 

 

 

2018

 

 

2019

 

 

2020

 

Net revenues

 

$

3,000,790

 

 

$

3,520,543

 

 

$

3,709,377

 

Cost of revenue

 

 

1,921,768

 

 

 

2,294,688

 

 

 

2,418,137

 

Gross profit

 

$

1,079,022

 

 

$

1,225,855

 

 

$

1,291,240

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

693,865

 

 

 

794,901

 

 

 

789,849

 

Amortization of acquired intangible assets

 

 

38,850

 

 

 

32,612

 

 

 

43,343

 

Other operating (income) expense, net

 

 

(1,845

)

 

 

(31,034

)

 

 

19,331

 

Income from operations

 

$

348,152

 

 

$

429,376

 

 

$

438,717

 

Foreign exchange gains (losses), net

 

 

15,239

 

 

 

7,729

 

 

 

7,482

 

Interest income (expense), net

 

 

(37,119

)

 

 

(43,458

)

 

 

(48,960

)

Other income (expense), net

 

 

35,761

 

 

 

5,786

 

 

 

3,238

 

Income before equity-method investment activity, net and income tax expense

 

$

362,033

 

 

$

399,433

 

 

$

400,477

 

Equity-method investment activity, net

 

 

(12

)

 

 

(16

)

 

 

 

Income before income tax expense

 

$

362,021

 

 

$

399,417

 

 

$

400,477

 

Income tax expense

 

 

80,763

 

 

 

94,536

 

 

 

92,201

 

Net income

 

$

281,258

 

 

$

304,881

 

 

$

308,276

 

Net loss (income) attributable to redeemable non-controlling interest

 

 

761

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

282,019

 

 

$

304,881

 

 

$

308,276

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to Genpact Limited common shareholders

 

$

282,019

 

 

$

304,881

 

 

$

308,276

 

Earnings per common share attributable to Genpact Limited common

shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.48

 

 

$

1.60

 

 

$

1.62

 

Diluted

 

$

1.45

 

 

$

1.56

 

 

$

1.57

 

Weighted average number of common shares used in computing earnings per common share attributable to Genpact Limited common shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

190,674,740

 

 

 

190,074,475

 

 

 

190,396,780

 

Diluted

 

 

193,980,038

 

 

 

195,160,855

 

 

 

195,780,971

 

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

 

 

Year ended December 31,

 

 

 

2018

 

 

2019

 

 

2020

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

282,019

 

 

$

304,881

 

 

$

308,276

 

Net loss attributable to redeemable non-controlling interest

 

 

(761

)

 

 

 

 

 

 

Net income

 

$

281,258

 

 

$

304,881

 

 

$

308,276

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

64,868

 

 

 

96,101

 

 

 

116,499

 

Amortization of debt issuance costs (including loss on extinguishment of debt)

 

 

3,975

 

 

 

1,779

 

 

 

2,248

 

Amortization of acquired intangible assets

 

 

38,850

 

 

 

32,612

 

 

 

43,343

 

Write-down of intangible assets and property, plant and equipment

 

 

4,265

 

 

 

3,511

 

 

 

14,083

 

Reserve for doubtful receivables/allowance for credit losses

 

 

1,857

 

 

 

7,443

 

 

 

5,707

 

Unrealized loss (gain) on revaluation of foreign currency asset/liability

 

 

3,352

 

 

 

(5,171

)

 

 

9,578

 

Stock-based compensation expense

 

 

48,998

 

 

 

83,885

 

 

 

74,008

 

Deferred tax expense (benefit)

 

 

6,054

 

 

 

(16,315

)

 

 

(22,587

)

Write-down of operating lease right-of-use assets and other assets

 

 

 

 

 

 

 

 

18,084

 

Gain on exchange of non-monetary asset

 

 

 

 

 

(31,380

)

 

 

 

Others, net

 

 

1,329

 

 

 

(2,213

)

 

 

(1,291

)

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

(Increase) decrease in accounts receivable

 

 

(76,894

)

 

 

(121,983

)

 

 

42,505

 

Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets

 

 

(76,392

)

 

 

(69,813

)

 

 

(99,852

)

Increase (decrease) in accounts payable

 

 

26,401

 

 

 

(21,375

)

 

 

(12,480

)

Increase in accrued expenses, other current liabilities, operating lease liabilities and other liabilities

 

 

5,993

 

 

 

157,580

 

 

 

87,180

 

Increase (decrease) in income taxes payable

 

 

5,597

 

 

 

8,346

 

 

 

(993

)

Net cash provided by operating activities

 

$

339,511

 

 

$

427,888

 

 

$

584,308

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(84,978

)

 

 

(74,927

)

 

 

(70,170

)

Payment for internally generated intangible assets (including intangibles under development)

 

 

(75,439

)

 

 

(33,834

)

 

 

(10,201

)

Proceeds from sale of property, plant and equipment

 

 

668

 

 

 

1,750

 

 

 

607

 

Proceeds from sale of equity affiliates

 

 

 

 

 

2,168

 

 

 

 

Payment for business acquisitions, net of cash acquired

 

 

(111,571

)

 

 

(252,276

)

 

 

(186,633

)

Payment for redeemable non-controlling interest

 

 

(4,730

)

 

 

 

 

 

 

Net cash used for investing activities

 

$

(276,050

)

 

$

(357,119

)

 

$

(266,397

)

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Repayment of capital/finance lease obligations

 

 

(2,395

)

 

 

(7,380

)

 

 

(10,567

)

Payment of debt issuance costs

 

 

(4,293

)

 

 

(2,317

)

 

 

(620

)

Proceeds from long-term debt

 

 

129,186

 

 

 

400,000

 

 

 

 

Repayment of long-term debt

 

 

(166,186

)

 

 

(34,000

)

 

 

(34,000

)

Proceeds from short-term borrowings

 

 

250,000

 

 

 

400,000

 

 

 

610,000

 

Repayment of short-term borrowings

 

 

(125,000

)

 

 

(625,000

)

 

 

(430,000

)

Proceeds from issuance of common shares under stock-based compensation plans

 

 

14,034

 

 

 

19,670

 

 

 

25,135

 

Payment for net settlement of stock-based awards

 

 

(15,919

)

 

 

(3,850

)

 

 

(34,083

)

Payment of earn-out consideration

 

 

(3,356

)

 

 

(12,790

)

 

 

(6,552

)

Dividend paid

 

 

(57,102

)

 

 

(64,671

)

 

 

(74,212

)

Payment for stock repurchased and retired (including expenses related to stock repurchase)

 

 

(154,156

)

 

 

(30,015

)

 

 

(137,112

)

Net cash provided by/ (used for) financing activities

 

$

(135,187

)

 

$

39,647

 

 

$

(92,011

)

Effect of exchange rate changes

 

 

(64,346

)

 

 

(11,716

)

 

 

(12,556

)

Net increase (decrease) in cash and cash equivalents

 

 

(71,726

)

 

 

110,416

 

 

 

225,900

 

Cash and cash equivalents at the beginning of the period

 

 

504,468

 

 

 

368,396

 

 

 

467,096

 

Cash and cash equivalents at the end of the period

 

$

368,396

 

 

$

467,096

 

 

$

680,440

 

Supplementary information

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid during the period for interest on borrowings (including interest rate swaps)

 

$

41,484

 

 

$

45,084

 

 

$

49,101

 

Cash paid during the period for income taxes, net of refunds

 

$

81,411

 

 

$

104,217

 

 

$

193,946

 

Property, plant and equipment acquired under capital/finance lease obligations

 

$

2,031

 

 

$

5,008

 

 

$

29,526

 

Non-cash transaction: Gain on exchange of non-monetary asset

 

$

 

 

$

(31,380

)

 

$

 

 

 


 

Non-GAAP Financial Measures

To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:

 

Adjusted income from operations;

 

Adjusted income from operations margin;

 

Adjusted diluted earnings per share; and

 

Revenue growth on a constant currency basis.

These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact’s GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.

Prior to July 2012, Genpact’s management used financial statements that excluded significant acquisition-related expenses, amortization of related acquired intangibles, and amortization of acquired intangibles recorded at the company’s formation in 2004 for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to that of its competitors. However, considering Genpact’s frequent acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact’s management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to those of its competitors. For the same reasons, since April 2016 Genpact’s management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated.

Genpact’s management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 “Compensation-Stock Compensation,” Genpact’s management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact’s operating results and those of other companies. During the second quarter of 2020, as a result of the COVID-19 pandemic, the Company initiated restructuring measures. In connection with the restructuring, the Company has recorded a charge related to the following: i) right-of-use lease assets and other assets related to certain abandoned leased office properties in the second quarter of 2020, and ii) employee severance costs related to a focused reduction in Genpact’s workforce in the second and third quarters of 2020. Genpact’s management believes that excluding such charges provides useful information to both management and investors regarding the Company’s financial performance and underlying business trends. Additionally, in its calculations of non-GAAP financial measures, Genpact’s management has adjusted foreign exchange gains and losses, interest income and expense and income tax expenses from GAAP net income, and other income and expenses, and certain gains, losses and impairment charges attributable to equity-method investments from GAAP income from operations, because management believes that the Company’s results after taking into account these adjustments more accurately reflect the Company’s ongoing operations. In its calculations of adjusted diluted earnings per share, Genpact’s management has adjusted stock-based compensation expense, amortization and impairment of acquired intangible assets, acquisition-related expenses and restructuring expenses and the related tax impact of such adjustments from GAAP diluted earnings per share. For the purpose of calculating adjusted diluted earnings per share, the combined current and deferred tax effect is determined by multiplying each pre-tax adjustment by the applicable statutory income tax rate.

Genpact’s management provides information about revenues on a constant currency basis so that the revenues may be viewed without the impact of foreign currency exchange rate fluctuations compared to prior fiscal periods, thereby facilitating period-to-period comparisons of the Company’s true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.

Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company’s reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.

 


 

A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income and net income margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation expense and amortization and impairment of acquired intangible assets. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.

 

The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the year and three months ended December 31, 2019 and 2020:

Reconciliation of Net income attributable to Genpact Limited shareholders/Margin to Adjusted Income from Operations/Margin

(In thousands)

 

 

 

Year ended December 31,

 

 

Three months ended December 31,

 

 

 

2019

 

 

2020

 

 

2019

 

 

2020

 

Net income attributable to Genpact Limited shareholders

 

$

304,881

 

 

$

308,276

 

 

$

82,198

 

 

$

74,982

 

Foreign exchange (gains) losses, net

 

 

(7,729

)

 

 

(7,482

)

 

 

(4,083

)

 

 

4,129

 

Interest (income) expense, net

 

 

43,458

 

 

 

48,960

 

 

 

9,971

 

 

 

10,888

 

Income tax expense

 

 

94,536

 

 

 

92,201

 

 

 

32,151

 

 

 

25,346

 

Stock-based compensation expense

 

 

83,885

 

 

 

74,008

 

 

 

22,579

 

 

 

18,190

 

Amortization and impairment of acquired intangible assets

 

 

31,458

 

 

 

43,648

 

 

 

8,768

 

 

 

11,430

 

Restructuring expenses

 

 

-

 

 

 

26,547

 

 

 

-

 

 

 

-

 

Acquisition-related expenses

 

 

8,352

 

 

 

2,650

 

 

 

7,385

 

 

 

2,650

 

Adjusted income from operations

 

$

558,841

 

 

$

588,808

 

 

$

158,969

 

 

$

147,615

 

Net income attributable to Genpact Limited shareholders margin

 

 

8.7

%

 

 

8.3

%

 

 

8.7

%

 

 

7.9

%

Adjusted income from operations margin

 

 

15.9

%

 

 

15.9

%

 

 

16.9

%

 

 

15.5

%

 

 

 

Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin

(In thousands)

 

 

 

Year ended December 31,

 

 

Three months ended December 31,

 

 

 

2019

 

 

2020

 

 

2019

 

 

2020

 

Income from operations

 

$

429,376

 

 

$

438,717

 

 

$

119,518

 

 

$

113,053

 

Stock-based compensation expense

 

 

83,885

 

 

 

74,008

 

 

 

22,579

 

 

 

18,190

 

Amortization and impairment of acquired intangible assets

 

 

31,458

 

 

 

43,648

 

 

 

8,768

 

 

 

11,430

 

Acquisition-related expenses

 

 

8,352

 

 

 

2,650

 

 

 

7,385

 

 

 

2,650

 

Other income (expense), net

 

 

5,786

 

 

 

3,238

 

 

 

719

 

 

 

2,292

 

Restructuring expenses

 

 

-

 

 

 

26,547

 

 

 

-

 

 

 

-

 

Equity-method investment activity, net

 

 

(16

)

 

 

-

 

 

 

-

 

 

 

-

 

Adjusted income from operations

 

$

558,841

 

 

$

588,808

 

 

$

158,969

 

 

$

147,615

 

Income from operations margin

 

 

12.2

%

 

 

11.8

%

 

 

12.7

%

 

 

11.9

%

Adjusted income from operations margin

 

 

15.9

%

 

 

15.9

%

 

 

16.9

%

 

 

15.5

%

 

 

 


 

Reconciliation of Diluted EPS to Adjusted Diluted EPS8

(Per share data) 

 

 

 

Year ended December 31,

 

 

Three months ended December 31,

 

 

 

2019

 

 

2020

 

 

2019

 

 

2020

 

Diluted EPS

 

$

1.56

 

 

$

1.57

 

 

$

0.42

 

 

$

0.38

 

Stock-based compensation expense

 

 

0.43

 

 

 

0.38

 

 

 

0.11

 

 

 

0.09

 

Amortization and impairment of acquired intangible assets

 

 

0.16

 

 

 

0.22

 

 

 

0.04

 

 

 

0.06

 

Acquisition-related expenses

 

 

0.04

 

 

 

0.01

 

 

 

0.04

 

 

 

0.01

 

Restructuring expenses

 

 

-

 

 

 

0.14

 

 

 

-

 

 

 

-

 

Tax impact on stock-based compensation expense

 

 

(0.10

)

 

 

(0.11

)

 

 

(0.02

)

 

 

(0.03

)

Tax impact on amortization and impairment of acquired intangible assets

 

 

(0.04

)

 

 

(0.06

)

 

 

(0.01

)

 

 

(0.01

)

Tax impact on acquisition-related expenses

 

 

(0.01

)

 

 

(0.00

)

 

 

(0.01

)

 

 

(0.00

)

Tax impact on restructuring expenses

 

 

-

 

 

 

(0.03

)

 

 

-

 

 

 

-

 

Adjusted diluted EPS

 

$

2.05

 

 

$

2.12

 

 

$

0.57

 

 

$

0.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.


 


The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending December 31, 2021:

 

Reconciliation of Outlook for Net income attributable to Genpact Limited shareholders Margin to Adjusted Income from Operations Margin9

 

 

 

Year ending December 31, 2021

 

Net income attributable to Genpact Limited shareholders margin

 

 

8.8

%

Estimated interest (income) expense, net

 

 

1.1

%

Estimated income tax expense

 

 

2.8

%

Estimated stock-based compensation expense

 

 

1.9

%

Estimated amortization of acquired intangible assets

 

 

1.4

%

Adjusted income from operations margin

 

 

16.0

%

 

 

 

Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from Operations Margin9

 

 

 

Year ending December 31, 2021

 

Income from operations margin

 

 

12.6

%

Estimated stock-based compensation expense

 

 

1.9

%

Estimated amortization of acquired intangible assets

 

 

1.4

%

Estimated other income (expense), net

 

 

0.1

%

Adjusted income from operations margin

 

 

16.0

%

 

 

 

Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS9

(Per share data)

 

 

 

Year ending December 31, 2021

 

 

 

Lower

 

 

Upper

 

Diluted EPS

 

$

1.77

 

 

 

1.80

 

Estimated stock-based compensation expense

 

 

0.38

 

 

 

0.38

 

Estimated amortization of acquired intangible assets

 

 

0.29

 

 

 

0.29

 

Estimated tax impact on stock-based compensation expense

 

 

(0.11

)

 

 

(0.11

)

Estimated tax impact on amortization of acquired intangible assets

 

 

(0.08

)

 

 

(0.08

)

Adjusted diluted EPS

 

$

2.26

 

 

 

2.29

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.